Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 4,394,000	$ 3,323,290
Other receivable	19,884	2,880
Other assets	144,652	39,352
Total current assets	4,558,536	3,365,522
Long-term assets
Property and equipment - net	149,904	19,466
Deferred compensation	1,041,666	1,250,001
Total assets	5,750,106	4,634,989
Current liabilities
Accounts payable	193,144	152,445
Notes payable	1,104,184	1,547,695
Notes payable CARES Act PPP Loan	121,807
Due to related parties	50,000	50,000
Accrued expenses	82,701	938
Accrued dividends	48,079	48,079
Total current liabilities	1,599,915	1,799,157
Long-term liabilities
Long-term notes payable	1,000,000	1,000,000
Long-term notes payable CARES Act PPP Loan	12,181	133,462
Total liabilities	2,612,096	2,932,619
Commitments and Contingencies (Note 9)
Stockholders’ Equity
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at March 31, 2021 and December 31, 2020 (Liquidation preference $340,050 and 340,050, respectively)	14	14
Common stock, $.001 par value, 500,000,000 shares authorized; 199,380,831 and 190,529,320 shares issued and outstanding at March 31, 2021 and at December 31, 2020, respectively	199,381	190,529
Additional paid-in capital	96,291,817	93,778,591
Accumulated deficit	(93,353,202)	(92,266,764)
Total stockholders’ equity	3,138,010	1,702,370
Total Liabilities and Stockholders’ Equity	$ 5,750,106	$ 4,634,989